Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.

CONCLUSIONS: Antiemetic prophylaxis with fosaprepitant and granisetron was well tolerated, safe, and effective in pediatric patients undergoing alloHSCT. However, larger prospective trials are necessary to evaluate these findings.
PMID: 32056007 [PubMed - as supplied by publisher]

Source: Clin Med Res - February 12, 2020 Category: Research Authors: Cabanillas Stanchi KM, Vek J, Schlegel P, Rupprecht JV, Flaadt T, Weber S, Michaelis S, Lang P, Handgretinger R, Döring M Tags: J Cancer Res Clin Oncol Source Type: research